Ascorbic Acid Improves Pluripotency of Human Parthenogenetic Embryonic Stem Cells Through Modifying Imprinted Gene Expression in the Dlk1-Dio3 Region

Yang Yu,Qian Gao,Hong-cui Zhao,Rong Li,Jiang-man Gao,Ting Ding,Si-yu Bao,Yue Zhao,Xiao-fang Sun,Yong Fan,Jie Qiao
DOI: https://doi.org/10.1186/s13287-015-0054-9
2015-01-01
Stem Cell Research & Therapy
Abstract:INTRODUCTION:Human parthenogenetic embryonic stem cells (hpESCs) are generated from artificially activated oocytes, however, the issue of whether hpESCs have equivalent differentiation ability to human fertilized embryonic stem cells remains controversial.METHODS:hpESCs were injected into male severe combined immunodeficiency (SCID) mice and the efficiency of teratoma formation was calculated. Then the gene expression and methylation modification were detected by real time-PCR and bisulfate methods.RESULTS:Comparison of five hpESCs with different differentiation abilities revealed that levels of paternal genes in the Dlk1-Dio3 region on chromosome 14 in the hpESCs with high differentiation potential are enhanced, but strictly methylated and silenced in the hpESCs with lower differentiation potential. Treatment with ascorbic acid, rescued their ability to support teratoma formation and altered the expression profiles of paternally expressed genes in hpESCs that could not form teratoma easily. No differences in the expression of other imprinting genes were evident between hpESCs with higher and lower differentiation potential, except for those in the Dlk1-Dio3 region.CONCLUSIONS:The Dlk1-Dio3 imprinting gene cluster distinguishes the differentiation ability of hpESCs. Moreover, modification by ascorbic acid may facilitate application of hpESCs to clinical settings in the future by enhancing their pluripotency.
What problem does this paper attempt to address?